Beer Flavor Provokes Striatal Dopamine Release in Male Drinkers: Mediation by Family History of Alcoholism
Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's cl...
Saved in:
Published in | Neuropsychopharmacology (New York, N.Y.) Vol. 38; no. 9; pp. 1617 - 1624 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Nature Publishing Group
01.08.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [(11)C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [(11)C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [(11)C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism. |
---|---|
AbstractList | Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [(11)C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [(11)C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [(11)C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism. Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [ super(11)C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [ super(11)C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [ super(11)C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism. Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [(11)C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [(11)C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [(11)C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism.Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [(11)C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [(11)C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [(11)C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism. Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [ 11 C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [ 11 C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [ 11 C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism. |
Author | Soeurt, Christina M Kareken, David A Albrecht, Daniel S Oberlin, Brandon G Tran, Stella M Yoder, Karmen K Dzemidzic, Mario |
Author_xml | – sequence: 1 givenname: Brandon G surname: Oberlin fullname: Oberlin, Brandon G – sequence: 2 givenname: Mario surname: Dzemidzic fullname: Dzemidzic, Mario – sequence: 3 givenname: Stella M surname: Tran fullname: Tran, Stella M – sequence: 4 givenname: Christina M surname: Soeurt fullname: Soeurt, Christina M – sequence: 5 givenname: Daniel S surname: Albrecht fullname: Albrecht, Daniel S – sequence: 6 givenname: Karmen K surname: Yoder fullname: Yoder, Karmen K – sequence: 7 givenname: David A surname: Kareken fullname: Kareken, David A |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23588036$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks1v1DAQxS1URLeFE3dkiQsSyuKJk9jhUKm0LEVqBeJD6s1yvBPqrWMHO7vS_vd4-4Gg4sDJ0vg3T29m3gHZ88EjIc-BzYFx-caP47xkwOctPCIzEBUrGl5d7pEZky0vgPPLfXKQ0ooxqEUjn5D9ktdSMt7MyOodYqQLpzch0s8xbMI1Jvp1ilZP2tHTMOrBeqRf0KFOSK2nF9ohPY3WX2NMb-kFLjNrg6fdli4y7bb0zKYpxC0NPT12JlwFZ9PwlDzutUv47O49JN8X77-dnBXnnz58PDk-L0wl6qloOe861sgWRY0AqKtcRlayXvR1ZToBeml0HlxXPQfGpNSyqY3oSwMIfckPydGt7rjuBlwa9FPUTo3RDjpuVdBW_f3j7ZX6ETaKCxB11WSBV3cCMfxcY5rUYJNB57THsE4KKmh5A5WE_0AZa8pStHVGXz5AV2Edfd7EDQX5ViAz9eJP879d318sA3ALmBhSitgrY6eb_edZrFPA1C4VKqdC7VKh2p3L1w967mX_Rf8CI5O4mg |
CODEN | NEROEW |
CitedBy_id | crossref_primary_10_1016_j_tips_2014_04_002 crossref_primary_10_1016_j_bcp_2013_07_007 crossref_primary_10_1111_gbb_12349 crossref_primary_10_3389_fnins_2019_00583 crossref_primary_10_1016_j_neubiorev_2019_10_009 crossref_primary_10_1152_jn_00564_2013 crossref_primary_10_1007_s00213_018_4968_7 crossref_primary_10_1080_00952990_2016_1257633 crossref_primary_10_1111_acer_13027 crossref_primary_10_1007_s12561_017_9208_x crossref_primary_10_1016_j_biopsycho_2016_05_002 crossref_primary_10_1038_npp_2017_298 crossref_primary_10_1016_j_bpsc_2018_03_018 crossref_primary_10_3934_molsci_2021016 crossref_primary_10_1016_j_drugalcdep_2016_01_001 crossref_primary_10_1111_acer_13417 crossref_primary_10_1016_j_neubiorev_2020_04_004 crossref_primary_10_1111_adb_12766 crossref_primary_10_1111_acer_15511 crossref_primary_10_1016_j_pscychresns_2024_111809 crossref_primary_10_1111_acer_15032 crossref_primary_10_1007_s00213_014_3850_5 crossref_primary_10_1007_s11682_018_0023_x crossref_primary_10_1016_j_bpsc_2016_06_005 crossref_primary_10_1016_j_drugalcdep_2019_02_028 crossref_primary_10_1093_chemse_bjy071 crossref_primary_10_1016_j_pscychresns_2016_01_006 crossref_primary_10_1016_j_drugalcdep_2015_10_021 crossref_primary_10_1016_j_pscychresns_2015_04_010 crossref_primary_10_1111_acer_12515 crossref_primary_10_3390_foods9060821 crossref_primary_10_1111_acer_13403 crossref_primary_10_1111_adb_12599 crossref_primary_10_1016_j_physbeh_2017_09_027 crossref_primary_10_1007_s00213_014_3720_1 crossref_primary_10_1007_s11682_017_9822_8 crossref_primary_10_1038_s41386_021_01157_5 crossref_primary_10_1111_acer_13516 crossref_primary_10_1177_1073191119864659 crossref_primary_10_1002_syn_70007 crossref_primary_10_1016_j_alcohol_2021_01_003 crossref_primary_10_3390_app132212402 crossref_primary_10_1016_j_drugalcdep_2021_108920 crossref_primary_10_1016_j_cobeha_2016_11_011 crossref_primary_10_1111_acer_13158 crossref_primary_10_1016_j_pscychresns_2023_111685 crossref_primary_10_1111_adb_12424 crossref_primary_10_3390_nu14193925 crossref_primary_10_1007_s13311_019_00817_1 crossref_primary_10_1016_j_appet_2019_104486 crossref_primary_10_1007_s11682_015_9374_8 |
Cites_doi | 10.1001/archpsyc.1990.01810180067010 10.1016/j.biopsych.2010.09.049 10.1046/j.1360-0443.2000.9568896.x 10.1016/j.biopsych.2005.04.044 10.1016/j.biopsych.2010.06.005 10.1081/SCC-120034174 10.2174/157340511795445694 10.1523/JNEUROSCI.1544-06.2006 10.3758/BF03342209 10.1111/j.1369-1600.2012.00464.x 10.1111/j.1530-0277.1999.tb04082.x 10.1097/01.WCB.0000085441.37552.CA 10.1097/JCP.0b013e3181e75cff 10.1111/j.1471-4159.2005.03137.x 10.1002/syn.890130407 10.1111/j.1530-0277.2008.00821.x 10.1016/j.pharmthera.2004.06.002 10.1097/00004647-200109000-00002 10.1002/syn.10226 10.1016/j.neuroimage.2009.11.076 10.1001/archpsyc.61.12.1246 10.1007/s00213-006-0578-x 10.1023/A:1020266306135 10.1038/sj.npp.1301513 10.1016/S0893-133X(02)00366-4 10.1523/JNEUROSCI.22-14-06247.2002 10.1016/j.jneumeth.2006.05.035 10.1016/j.tins.2007.03.007 10.1038/mp.2010.56 10.1016/S0166-4328(02)00282-6 10.1038/sj.jcbfm.9600493 10.1038/nature01476 10.1001/archpsyc.60.7.727 10.1007/s00213-004-1828-4 10.1016/j.neuroimage.2012.02.006 10.1093/chemse/21.3.323 10.1002/ana.20822 10.1016/0306-4522(95)00255-H 10.1038/npp.2009.129 10.1016/j.neuroimage.2007.09.059 10.15288/jsa.1994.55.149 10.1097/01.ALC.0000089959.66222.B8 10.1523/JNEUROSCI.5578-03.2004 10.1038/sj.npp.1301194 10.1111/j.1530-0277.2006.00130.x 10.1523/JNEUROSCI.3371-07.2007 10.1111/j.1460-9568.2011.07642.x 10.1016/j.neuroimage.2006.11.043 10.1111/j.1360-0443.2008.02250.x 10.1037/0021-843X.106.2.243 |
ContentType | Journal Article |
Copyright | Copyright Nature Publishing Group Aug 2013 Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology |
Copyright_xml | – notice: Copyright Nature Publishing Group Aug 2013 – notice: Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 7QR 8FD FR3 P64 5PM |
DOI | 10.1038/npp.2013.91 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database ProQuest Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic Chemoreception Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Chemoreception Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | MEDLINE Chemoreception Abstracts ProQuest One Psychology MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Beer flavor provokes striatal dopamine release |
EISSN | 1740-634X |
EndPage | 1624 |
ExternalDocumentID | PMC3717546 3020276531 23588036 10_1038_npp_2013_91 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | Indiana United States--US Indianapolis Indiana |
GeographicLocations_xml | – name: United States--US – name: Indiana – name: Indianapolis Indiana |
GrantInformation_xml | – fundername: NIAAA NIH HHS grantid: P60 AA007611 – fundername: NIAAA NIH HHS grantid: R01 AA018354 – fundername: NIAAA NIH HHS grantid: T32 AA007462 – fundername: NCATS NIH HHS grantid: TR000006 – fundername: NIAAA NIH HHS grantid: R01 AA017661 – fundername: NCATS NIH HHS grantid: UL1 TR000006 |
GroupedDBID | --- -DZ -Q- 0R~ 29N 2WC 36B 39C 4.4 406 5RE 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AANZL AASML AAYXX AAYZH ABAKF ABBRH ABDBE ABFSG ABIVO ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMFV ACMJI ACPRK ACRQY ACSTC ACZOJ ADBBV ADFRT AEFQL AEJRE AEMSY AENEX AESKC AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AOIJS ASPBG ATHPR AVWKF AYFIA AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CITATION CS3 DIK DNIVK DPUIP DWQXO E3Z EBLON EBS EE. EIOEI EJD EMB EMOBN F5P FDB FDQFY FERAY FIZPM FSGXE FYUFA GNUQQ GX1 HCIFZ HMCUK HYE HZ~ IWAJR JSO JZLTJ KQ8 M1P M2M M7P MK0 NQJWS O9- OK1 P2P P6G PHGZM PHGZT PQQKQ PROAC PSQYO PSYQQ Q2X RNT RNTTT ROL RPM SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TR2 UKHRP W2D ZGI --K 1B1 53G 5VS AACDK AAEDT AALRI AAQFI AAQXK AATNV AAXUO ABMAC ABWVN ACIUM ACRPL ADMUD ADNMO AILAN CAG CGR COF CUY CVF ECM EIF FEDTE FGOYB FIGPU HVGLF IHE LGEZI LOTEE M41 NADUK NPM NQ- NXXTH R2- RIG RNS RPZ SEW SSZ ZKB 3V. 7TK 7XB 8FE 8FH 8FK ABRTQ K9. LK8 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 PUEGO 7QR 8FD FR3 P64 5PM |
ID | FETCH-LOGICAL-c475t-933bb0689e75e11ea4475e020f7f54cb71adca038a4f310088a865c7f2c1e1f23 |
IEDL.DBID | 7X7 |
ISSN | 0893-133X 1740-634X |
IngestDate | Thu Aug 21 13:47:29 EDT 2025 Fri Jul 11 06:28:54 EDT 2025 Sun Aug 24 04:11:26 EDT 2025 Fri Jul 25 08:54:32 EDT 2025 Thu Apr 03 06:52:58 EDT 2025 Tue Jul 01 01:05:25 EDT 2025 Thu Apr 24 23:03:14 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c475t-933bb0689e75e11ea4475e020f7f54cb71adca038a4f310088a865c7f2c1e1f23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://www.nature.com/articles/npp201391.pdf |
PMID | 23588036 |
PQID | 1400189318 |
PQPubID | 33935 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3717546 proquest_miscellaneous_1419361481 proquest_miscellaneous_1400622795 proquest_journals_1400189318 pubmed_primary_23588036 crossref_citationtrail_10_1038_npp_2013_91 crossref_primary_10_1038_npp_2013_91 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-08-01 |
PublicationDateYYYYMMDD | 2013-08-01 |
PublicationDate_xml | – month: 08 year: 2013 text: 2013-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York |
PublicationTitle | Neuropsychopharmacology (New York, N.Y.) |
PublicationTitleAlternate | Neuropsychopharmacology |
PublicationYear | 2013 |
Publisher | Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group |
References | H Myrick (BFnpp201391_CR34) 2010; 30 ND Volkow (BFnpp201391_CR45) 2006; 26 F Weiss (BFnpp201391_CR48) 1993; 267 ED London (BFnpp201391_CR27) 1990; 47 MS Brodie (BFnpp201391_CR6) 1999; 23 SN Haber (BFnpp201391_CR19) 2010; 35 M Ichise (BFnpp201391_CR20) 2003; 23 KK Yoder (BFnpp201391_CR53) 2009; 33 SF Tapert (BFnpp201391_CR43) 2003; 60 WM Doyon (BFnpp201391_CR10) 2005; 93 DF Wong (BFnpp201391_CR49) 2006; 31 AH Evans (BFnpp201391_CR12) 2006; 59 RB Innis (BFnpp201391_CR21) 2007; 27 C Besson (BFnpp201391_CR3) 1995; 68 MM Andrews (BFnpp201391_CR1) 2011; 69 WM Doyon (BFnpp201391_CR11) 2003; 27 D Martinez (BFnpp201391_CR30) 2005; 58 EG Singleton (BFnpp201391_CR42) 2000 RA Gonzales (BFnpp201391_CR16) 2004; 103 LJ Porrino (BFnpp201391_CR37) 2004; 24 NL Cooney (BFnpp201391_CR8) 1997; 106 J Joutsa (BFnpp201391_CR23) 2012; 60 ND Volkow (BFnpp201391_CR46) 2007; 27 KK Bucholz (BFnpp201391_CR7) 1994; 55 W Schultz (BFnpp201391_CR41) 2007; 30 L Marciani (BFnpp201391_CR28) 2006; 158 JD Salamone (BFnpp201391_CR39) 2002; 137 M Leyton (BFnpp201391_CR25) 2002; 27 O Mawlawi (BFnpp201391_CR31) 2001; 21 CA Munro (BFnpp201391_CR32) 2006; 30 J Garcia (BFnpp201391_CR15) 1966; 4 DA Kareken (BFnpp201391_CR24) 2010; 50 R Ito (BFnpp201391_CR22) 2002; 22 C Martin-Soelch (BFnpp201391_CR29) 2011; 33 PE Phillips (BFnpp201391_CR36) 2003; 422 JI Nurnberger Jr (BFnpp201391_CR35) 2004; 61 NB Urban (BFnpp201391_CR44) 2010; 68 VA Ramchandani (BFnpp201391_CR38) 2011; 16 J Wrase (BFnpp201391_CR50) 2007; 35 ND Volkow (BFnpp201391_CR47) 2008; 39 JM Murphy (BFnpp201391_CR33) 2002; 32 MD Litt (BFnpp201391_CR26) 2000; 95 I Boileau (BFnpp201391_CR5) 2003; 49 FM Filbey (BFnpp201391_CR14) 2008; 33 BFnpp201391_CR13 SM Grüsser (BFnpp201391_CR18) 2004; 175 BG Green (BFnpp201391_CR17) 1996; 21 KK Yoder (BFnpp201391_CR51) 2004; 45 KC Berridge (BFnpp201391_CR2) 2007; 191 JP Schacht (BFnpp201391_CR40) 2012; 18 KK Yoder (BFnpp201391_CR52) 2011; 7 SL Dewey (BFnpp201391_CR9) 1993; 13 JM Bjork (BFnpp201391_CR4) 2008; 103 16971900 - Neuropsychopharmacology. 2006 Dec;31(12):2716-27 20678752 - Biol Psychiatry. 2010 Oct 15;68(8):689-96 17653109 - Neuropsychopharmacology. 2008 May;33(6):1391-401 21126735 - Biol Psychiatry. 2011 Apr 1;69(7):675-83 10591603 - Alcohol Clin Exp Res. 1999 Nov;23(11):1848-52 22348881 - Neuroimage. 2012 May 1;60(4):1992-9 15071103 - J Neurosci. 2004 Apr 7;24(14):3554-62 18851716 - Addiction. 2008 Aug;103(8):1308-19 12827641 - Synapse. 2003 Sep 15;49(4):226-31 15583116 - Arch Gen Psychiatry. 2004 Dec;61(12):1246-56 17291784 - Neuroimage. 2007 Apr 1;35(2):787-94 8670711 - Chem Senses. 1996 Jun;21(3):323-34 18003850 - J Neurosci. 2007 Nov 14;27(46):12700-6 20004725 - Neuroimage. 2010 Mar;50(1):267-76 12687000 - Nature. 2003 Apr 10;422(6932):614-8 16839610 - J Neurosci Methods. 2006 Dec 15;158(2):186-94 8480281 - Synapse. 1993 Apr;13(4):350-6 12973026 - J Cereb Blood Flow Metab. 2003 Sep;23(9):1096-112 15935063 - J Neurochem. 2005 Jun;93(6):1469-81 10946438 - Addiction. 2000 Jun;95(6):889-900 11524609 - J Cereb Blood Flow Metab. 2001 Sep;21(9):1034-57 16792561 - Alcohol Clin Exp Res. 2006 Jul;30(7):1143-51 18976347 - Alcohol Clin Exp Res. 2009 Jan;33(1):139-49 12464459 - Neuropsychopharmacology. 2002 Dec;27(6):1027-35 15136642 - J Nucl Med. 2004 May;45(5):903-11 15369680 - Pharmacol Ther. 2004 Aug;103(2):121-46 14574227 - Alcohol Clin Exp Res. 2003 Oct;27(10):1573-82 15127179 - Psychopharmacology (Berl). 2004 Sep;175(3):296-302 22574861 - Addict Biol. 2013 Jan;18(1):121-33 20571434 - J Clin Psychopharmacol. 2010 Aug;30(4):365-72 8189735 - J Stud Alcohol. 1994 Mar;55(2):149-58 2350209 - Arch Gen Psychiatry. 1990 Jun;47(6):567-74 12445713 - Behav Brain Res. 2002 Dec 2;137(1-2):3-25 12405517 - Behav Genet. 2002 Sep;32(5):363-88 17072591 - Psychopharmacology (Berl). 2007 Apr;191(3):391-431 17519979 - J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9 21453423 - Eur J Neurosci. 2011 May;33(9):1706-15 12122083 - J Neurosci. 2002 Jul 15;22(14):6247-53 8545002 - Neuroscience. 1995 Oct;68(4):963-8 9131844 - J Abnorm Psychol. 1997 May;106(2):243-50 8229752 - J Pharmacol Exp Ther. 1993 Oct;267(1):250-8 18024160 - Neuroimage. 2008 Feb 1;39(3):1266-73 16557571 - Ann Neurol. 2006 May;59(5):852-8 12860777 - Arch Gen Psychiatry. 2003 Jul;60(7):727-35 17400301 - Trends Neurosci. 2007 May;30(5):203-10 19812543 - Neuropsychopharmacology. 2010 Jan;35(1):4-26 16018986 - Biol Psychiatry. 2005 Nov 15;58(10):779-86 20479755 - Mol Psychiatry. 2011 Aug;16(8):809-17 16775146 - J Neurosci. 2006 Jun 14;26(24):6583-8 |
References_xml | – volume: 47 start-page: 567 year: 1990 ident: BFnpp201391_CR27 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1990.01810180067010 – volume: 69 start-page: 675 year: 2011 ident: BFnpp201391_CR1 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2010.09.049 – volume: 95 start-page: 889 year: 2000 ident: BFnpp201391_CR26 publication-title: Addiction doi: 10.1046/j.1360-0443.2000.9568896.x – volume-title: Alcohol Craving Questionnaire (ACQ-NOW): Background, Scoring, and Administration year: 2000 ident: BFnpp201391_CR42 – volume: 58 start-page: 779 year: 2005 ident: BFnpp201391_CR30 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.04.044 – volume: 68 start-page: 689 year: 2010 ident: BFnpp201391_CR44 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2010.06.005 – ident: BFnpp201391_CR13 doi: 10.1081/SCC-120034174 – volume: 7 start-page: 118 year: 2011 ident: BFnpp201391_CR52 publication-title: Curr Med Imag Rev doi: 10.2174/157340511795445694 – volume: 26 start-page: 6583 year: 2006 ident: BFnpp201391_CR45 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1544-06.2006 – volume: 4 start-page: 123 year: 1966 ident: BFnpp201391_CR15 publication-title: Psychonomic Science doi: 10.3758/BF03342209 – volume: 18 start-page: 121 year: 2012 ident: BFnpp201391_CR40 publication-title: Addict Biol doi: 10.1111/j.1369-1600.2012.00464.x – volume: 23 start-page: 1848 year: 1999 ident: BFnpp201391_CR6 publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.1999.tb04082.x – volume: 23 start-page: 1096 year: 2003 ident: BFnpp201391_CR20 publication-title: J Cereb Blood Flow Metab doi: 10.1097/01.WCB.0000085441.37552.CA – volume: 30 start-page: 365 year: 2010 ident: BFnpp201391_CR34 publication-title: J Clin Psychopharmacol doi: 10.1097/JCP.0b013e3181e75cff – volume: 93 start-page: 1469 year: 2005 ident: BFnpp201391_CR10 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2005.03137.x – volume: 13 start-page: 350 year: 1993 ident: BFnpp201391_CR9 publication-title: Synapse doi: 10.1002/syn.890130407 – volume: 33 start-page: 139 year: 2009 ident: BFnpp201391_CR53 publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.2008.00821.x – volume: 103 start-page: 121 year: 2004 ident: BFnpp201391_CR16 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2004.06.002 – volume: 45 start-page: 903 year: 2004 ident: BFnpp201391_CR51 publication-title: J Nucl Med – volume: 21 start-page: 1034 year: 2001 ident: BFnpp201391_CR31 publication-title: J Cereb Blood Flow Metab doi: 10.1097/00004647-200109000-00002 – volume: 49 start-page: 226 year: 2003 ident: BFnpp201391_CR5 publication-title: Synapse doi: 10.1002/syn.10226 – volume: 50 start-page: 267 year: 2010 ident: BFnpp201391_CR24 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2009.11.076 – volume: 61 start-page: 1246 year: 2004 ident: BFnpp201391_CR35 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.61.12.1246 – volume: 191 start-page: 391 year: 2007 ident: BFnpp201391_CR2 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-006-0578-x – volume: 32 start-page: 363 year: 2002 ident: BFnpp201391_CR33 publication-title: Behav Genet doi: 10.1023/A:1020266306135 – volume: 33 start-page: 1391 year: 2008 ident: BFnpp201391_CR14 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301513 – volume: 27 start-page: 1027 year: 2002 ident: BFnpp201391_CR25 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(02)00366-4 – volume: 22 start-page: 6247 year: 2002 ident: BFnpp201391_CR22 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.22-14-06247.2002 – volume: 158 start-page: 186 year: 2006 ident: BFnpp201391_CR28 publication-title: J Neurosci Methods doi: 10.1016/j.jneumeth.2006.05.035 – volume: 30 start-page: 203 year: 2007 ident: BFnpp201391_CR41 publication-title: Trends Neurosci doi: 10.1016/j.tins.2007.03.007 – volume: 16 start-page: 809 year: 2011 ident: BFnpp201391_CR38 publication-title: Mol Psychiatry doi: 10.1038/mp.2010.56 – volume: 137 start-page: 3 year: 2002 ident: BFnpp201391_CR39 publication-title: Behav Brain Res doi: 10.1016/S0166-4328(02)00282-6 – volume: 27 start-page: 1533 year: 2007 ident: BFnpp201391_CR21 publication-title: J Cereb Blood Flow Metab doi: 10.1038/sj.jcbfm.9600493 – volume: 422 start-page: 614 year: 2003 ident: BFnpp201391_CR36 publication-title: Nature doi: 10.1038/nature01476 – volume: 60 start-page: 727 year: 2003 ident: BFnpp201391_CR43 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.60.7.727 – volume: 175 start-page: 296 year: 2004 ident: BFnpp201391_CR18 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-004-1828-4 – volume: 60 start-page: 1992 year: 2012 ident: BFnpp201391_CR23 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2012.02.006 – volume: 267 start-page: 250 year: 1993 ident: BFnpp201391_CR48 publication-title: J Pharmacol Exp Ther – volume: 21 start-page: 323 year: 1996 ident: BFnpp201391_CR17 publication-title: Chem Senses doi: 10.1093/chemse/21.3.323 – volume: 59 start-page: 852 year: 2006 ident: BFnpp201391_CR12 publication-title: Ann Neurol doi: 10.1002/ana.20822 – volume: 68 start-page: 963 year: 1995 ident: BFnpp201391_CR3 publication-title: Neuroscience doi: 10.1016/0306-4522(95)00255-H – volume: 35 start-page: 4 year: 2010 ident: BFnpp201391_CR19 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2009.129 – volume: 39 start-page: 1266 year: 2008 ident: BFnpp201391_CR47 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2007.09.059 – volume: 55 start-page: 149 year: 1994 ident: BFnpp201391_CR7 publication-title: J Stud Alcohol doi: 10.15288/jsa.1994.55.149 – volume: 27 start-page: 1573 year: 2003 ident: BFnpp201391_CR11 publication-title: Alcohol Clin Exp Res doi: 10.1097/01.ALC.0000089959.66222.B8 – volume: 24 start-page: 3554 year: 2004 ident: BFnpp201391_CR37 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5578-03.2004 – volume: 31 start-page: 2716 year: 2006 ident: BFnpp201391_CR49 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301194 – volume: 30 start-page: 1143 year: 2006 ident: BFnpp201391_CR32 publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.2006.00130.x – volume: 27 start-page: 12700 year: 2007 ident: BFnpp201391_CR46 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3371-07.2007 – volume: 33 start-page: 1706 year: 2011 ident: BFnpp201391_CR29 publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2011.07642.x – volume: 35 start-page: 787 year: 2007 ident: BFnpp201391_CR50 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2006.11.043 – volume: 103 start-page: 1308 year: 2008 ident: BFnpp201391_CR4 publication-title: Addiction doi: 10.1111/j.1360-0443.2008.02250.x – volume: 106 start-page: 243 year: 1997 ident: BFnpp201391_CR8 publication-title: J Abnorm Psychol doi: 10.1037/0021-843X.106.2.243 – reference: 8545002 - Neuroscience. 1995 Oct;68(4):963-8 – reference: 15071103 - J Neurosci. 2004 Apr 7;24(14):3554-62 – reference: 18851716 - Addiction. 2008 Aug;103(8):1308-19 – reference: 20571434 - J Clin Psychopharmacol. 2010 Aug;30(4):365-72 – reference: 12445713 - Behav Brain Res. 2002 Dec 2;137(1-2):3-25 – reference: 16839610 - J Neurosci Methods. 2006 Dec 15;158(2):186-94 – reference: 15136642 - J Nucl Med. 2004 May;45(5):903-11 – reference: 19812543 - Neuropsychopharmacology. 2010 Jan;35(1):4-26 – reference: 20004725 - Neuroimage. 2010 Mar;50(1):267-76 – reference: 16018986 - Biol Psychiatry. 2005 Nov 15;58(10):779-86 – reference: 8229752 - J Pharmacol Exp Ther. 1993 Oct;267(1):250-8 – reference: 18024160 - Neuroimage. 2008 Feb 1;39(3):1266-73 – reference: 12405517 - Behav Genet. 2002 Sep;32(5):363-88 – reference: 10946438 - Addiction. 2000 Jun;95(6):889-900 – reference: 22348881 - Neuroimage. 2012 May 1;60(4):1992-9 – reference: 17653109 - Neuropsychopharmacology. 2008 May;33(6):1391-401 – reference: 8189735 - J Stud Alcohol. 1994 Mar;55(2):149-58 – reference: 2350209 - Arch Gen Psychiatry. 1990 Jun;47(6):567-74 – reference: 12464459 - Neuropsychopharmacology. 2002 Dec;27(6):1027-35 – reference: 8480281 - Synapse. 1993 Apr;13(4):350-6 – reference: 17400301 - Trends Neurosci. 2007 May;30(5):203-10 – reference: 12687000 - Nature. 2003 Apr 10;422(6932):614-8 – reference: 14574227 - Alcohol Clin Exp Res. 2003 Oct;27(10):1573-82 – reference: 9131844 - J Abnorm Psychol. 1997 May;106(2):243-50 – reference: 15583116 - Arch Gen Psychiatry. 2004 Dec;61(12):1246-56 – reference: 22574861 - Addict Biol. 2013 Jan;18(1):121-33 – reference: 10591603 - Alcohol Clin Exp Res. 1999 Nov;23(11):1848-52 – reference: 20678752 - Biol Psychiatry. 2010 Oct 15;68(8):689-96 – reference: 16775146 - J Neurosci. 2006 Jun 14;26(24):6583-8 – reference: 21126735 - Biol Psychiatry. 2011 Apr 1;69(7):675-83 – reference: 17291784 - Neuroimage. 2007 Apr 1;35(2):787-94 – reference: 12827641 - Synapse. 2003 Sep 15;49(4):226-31 – reference: 12122083 - J Neurosci. 2002 Jul 15;22(14):6247-53 – reference: 12973026 - J Cereb Blood Flow Metab. 2003 Sep;23(9):1096-112 – reference: 8670711 - Chem Senses. 1996 Jun;21(3):323-34 – reference: 16557571 - Ann Neurol. 2006 May;59(5):852-8 – reference: 16792561 - Alcohol Clin Exp Res. 2006 Jul;30(7):1143-51 – reference: 15127179 - Psychopharmacology (Berl). 2004 Sep;175(3):296-302 – reference: 12860777 - Arch Gen Psychiatry. 2003 Jul;60(7):727-35 – reference: 17519979 - J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9 – reference: 18003850 - J Neurosci. 2007 Nov 14;27(46):12700-6 – reference: 20479755 - Mol Psychiatry. 2011 Aug;16(8):809-17 – reference: 11524609 - J Cereb Blood Flow Metab. 2001 Sep;21(9):1034-57 – reference: 15935063 - J Neurochem. 2005 Jun;93(6):1469-81 – reference: 18976347 - Alcohol Clin Exp Res. 2009 Jan;33(1):139-49 – reference: 21453423 - Eur J Neurosci. 2011 May;33(9):1706-15 – reference: 15369680 - Pharmacol Ther. 2004 Aug;103(2):121-46 – reference: 17072591 - Psychopharmacology (Berl). 2007 Apr;191(3):391-431 – reference: 16971900 - Neuropsychopharmacology. 2006 Dec;31(12):2716-27 |
SSID | ssj0015768 |
Score | 2.3502355 |
Snippet | Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1617 |
SubjectTerms | Adult Alcohol use Alcoholism Alcoholism - genetics Alcoholism - psychology Beer Behavior, Addictive - metabolism Behavior, Addictive - psychology Brain Conditioning, Classical Corpus Striatum - metabolism Cues Dopamine Dopamine - metabolism Dopamine Antagonists Ethanol Family Health Functional Neuroimaging Genetic Predisposition to Disease - genetics Humans Intoxication Male Medicine Neurosciences Original Raclopride Tomography |
Title | Beer Flavor Provokes Striatal Dopamine Release in Male Drinkers: Mediation by Family History of Alcoholism |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23588036 https://www.proquest.com/docview/1400189318 https://www.proquest.com/docview/1400622795 https://www.proquest.com/docview/1419361481 https://pubmed.ncbi.nlm.nih.gov/PMC3717546 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED7BJiFeEHT8KIzJSNMe0MLiOIkdXlDHVk1InaqxSX2LbMfRCmtSkm5S_nvOTppRQHvOxYlydu473_n7APbRsRl3_HaJNB4icO0pzIQ8qSMRKJ4HmSvFTM7js6vw2yyadRtudddWuf4nuh91Vmq7R36EiYBPMbhS8WX5y7OqUba62kloPIZtS11mW7r4rE-4qMXSDkUmzMNcbNadz_OZOCqWlqySsk8J3YxI_8DMv7sl_wg_4-fwrMONZNQ6-gU8MsUAdkYF5syLhhwQ18nptsgH8GTSFcwHcDBtqambQ3J5f9KqPnR39KTVzQ78ODamIuMbeVdWZFqVd-VPU5PvVtQD4Tk5wdx6gSOSCwxTGPjIvCATjC3kpMJkFiHkZzJxoh_oZqIa0uppkJaEpCFlTkatFu-8XryEq_Hp5dczr9Nh8HTIo5WXMKaUH4vE8MhQaqQlCTSIM3OeR6FWnMpMS_yqMsxtvUAIKeJIo6M1NTQP2CvYKsrCvAHCVahjESWSWsLgQKswx6G1b3jGhEr8IXxc-yLVHUm51cq4SV2xnIkUHZdax6UJHcJ-b7xsuTn-b7a7dmraLdA6vZ9OQ_jQX8alZeslsjDlbWsTW4bF6CEbRMCWTBUf87qdJ_272FPIAhHCEPjGDOoNLLX35pVifu0ovhlm2VEYv3341d_B08Cpc9h-xF3YWlW35j1ipJXacwthD7aPT8-nF78BscETXA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD6aOgl4QdBxKQww0tgDWrY4VwcJoY6u6thSVaOT-hYSxxGFNSlJN5Q_xW_k2LmMAtrbnnPqWjrHPt_nY38HYAcdG7tK384LhYYInGsRMiEt5DYzIjcxYlWK8cfO6Nz6NLNnG_CreQsjr1U2e6LaqOOMyzPyAyQCOsXkStmH5Q9Ndo2S1dWmhUYVFiei_ImUrXh_PED_vjGM4dH040iruwpo3HLtlYYMPop0h3nCtQWlIpSSdwJRU-ImtsUjl4YxD3WThVYiT78ZC5ljc5w2p4ImUugAt_xNy0Qq04HNw6Px5KytW0j0rnCrZ2rI_mb1i0Ac7SBdSnlMau57dD0H_gNs_76f-UfCGz6A-zVSJf0qtB7Chki7sNVPkaUvSrJL1N1RdSjfhTt-XaLvwu6kEsMu98j0-m1Xsad-0cpkl1vw7VCInAwvwqssJ5M8u8q-i4J8lm1EkBCQAbL5BY5IzjAxYqol85T4mM3IIEf6jKD1HfFVmxEMLBKVpOrgQSrZk5JkCelX3X_nxeIRnN-Kjx5DJ81S8RSIG1ncYbYXUilRbPDISnBorgs3Nlnk6T142_gi4LUsuuzOcRGo8rzJAnRcIB0XeLQHO63xslID-b_ZduPUoN4SiuA6gHvwuv2Mi1lWaMJUZJeVjSM1He2bbBBzS_lW_JsnVZy0c5Hvnhlikh64axHUGkgx8fUv6fyrEhU3kdfblvPs5qm_grujqX8anB6PT57DPUP1BpG3Ibehs8ovxQtEaKvoZb0sCHy57ZX4G-axT1M |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIU28IOj4KAww0tgDWmicxLGDhFChVBujUwWb1LdgO44orElJuqH8a_x1nJ2PUUB723OuTqq7893Pd_4dQrug2IRZfrtIaAcycOVIQEKOUJR7kqVeYksxk-Pw4DT4MKOzDfSrvQtj2irbPdFu1EmuzBn5AICASyC4Ej5Im7aI6Wj8ZvnDMROkTKW1HadRm8iRrn4CfCtfH45A1889b_z-5N2B00wYcFTA6MoBNC-lG_JIM6oJ0cLQ32nIoFKW0kBJRkSihOtzEaTmJJxzwUOq4C8ooklqSA9g-7_BfEqMj7FZB_aIyeNtBhv5DuDAWXM3ENYaZEtDlEn8lxFZj4b_pLh_d2r-EfrGt9GtJmfFw9rI7qANnfXQ9jADvL6o8B62XaT2eL6HtiZNsb6H9qY1LXa1j08ub3mV-_YXHWF2tY2-vdW6wOMzcZEXeFrkF_l3XeLPZqAIQAM8Aly_gBXxJwiREHTxPMMTiGt4VACQhvT1FZ7YgSNgYlhWuJ7lgWsClArnKR7Wc4Dn5eIuOr0WDd1Dm1me6QcIMxmokNNIEENW7CkZpLC0cjVLfC4jt49etLqIVUOQbuZ0nMW2UO_zGBQXG8XFEemj3U54WfOC_F9sp1Vq3GwOZXxpyn30rHsMbm1qNSLT-XktExp2R3qVDGTfhsgVXnO_tpPuW8wNaA7ZSR-xNQvqBAyt-PqTbP7V0ov7gPBpED68-tOfoi3wv_jj4fHRI3TTs0NCTFvkDtpcFef6MaRqK_nE-gRGX67bCX8DtpNSIw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Beer+flavor+provokes+striatal+dopamine+release+in+male+drinkers%3A+mediation+by+family+history+of+alcoholism&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Oberlin%2C+Brandon+G&rft.au=Dzemidzic%2C+Mario&rft.au=Tran%2C+Stella+M&rft.au=Soeurt%2C+Christina+M&rft.date=2013-08-01&rft.eissn=1740-634X&rft.volume=38&rft.issue=9&rft.spage=1617&rft_id=info:doi/10.1038%2Fnpp.2013.91&rft_id=info%3Apmid%2F23588036&rft.externalDocID=23588036 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon |